[Suspected cases of severe side effects after infliximab (Remicade) in Germany].
Thürmann
Petra A
PA
D016907:Adverse Drug Reaction Reporting Systems / Q000706:statistics & numerical data*; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D003424:Crohn Disease / Q000188:drug therapy*; D017277:Drug Approval / Q000331:legislation & jurisprudence; D005858:Germany; D006801:Humans; D000069285:Infliximab; D007412:Intestinal Fistula / Q000188:drug therapy; D013167:Spondylitis, Ankylosing / Q000188:drug therapy; D014481:United States
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab